Table 5 Clinical and biochemical data of cirrhotic patients with MHE and no MHE

Age (Years, mean ± SD)

54.3 ± 13.9

(n = 37)

35.2 ± 10.9

(n = 13)

–

Male gender

20 (54.1%)

9 (69.2%)

0.52 [0.1–2.0]

Education (Years, mean ± SD)

7.9 ± 2.8

(n = 37)

14.3 ± 2.0

(n = 13)

–

CHILD–PUGH B/C

15 (48.4%)

2 (16.7%)

4.68 [0.8–24.9]

A

16 (51.6%)

10 (83.3%)

1

Jaundice (Yes/no)

8 (21.6%)

1 (7.7%)

3.31 [0.3–29.4]

Ascites (Yes/no)

14 (37.8%)

3 (23.1%)

2.02 [0.4–8.6]

Previous GI hemorrhage (Yes/no)

6 (16.2%)

2 (15.4%)

1.06 [0.1–6.0]

MELD score (Score, mean ± SD)

11.6 ± 3.7

(n = 15)

8.8 ± 2.6

(n = 7)

–

INR (Median, IQR)

1.2 [1.0–1.8]

(n = 13)

1.1 [1.0–1.6]

(n = 7)

–

Albumin (g/l, mean ± SD)

33.8 ± 7.0

(n = 21)

36.8 ± 7.3

(n = 5)

–

Creatinin (mg/dl, mean ± SD)

9.4 ± 3.4

(n = 31)

8.5 ± 1.8

(n = 11)

–

Prothrombin time (%)

65.7 ± 18.7

(n = 30)

59.6 ± 13.7

(n = 10)

–

Bilirubin (mg/dl, Median, IQR)

8.7 [1.1–68.0]

(n = 24)

10.0 [8.0–41.0]

(n = 7)

–

ALAT (IU/l, Median, IQR)

33 [15–155]

(n = 20)

46 [11–76]

(n = 12)

–

Platelets (/ml, Median, IQR)

110.10³ [15.10³–421.10³]

(n = 37)

91.10³ [42.10³–300.10³]

(n = 12)

–